Bottom line
What does FHCRX hold?
FHCRX held 152 positions as of May 31, 2026. Its largest holding is ELI LILLY and CO at 8.03% of the fund, and the top 10 positions add up to 38.8%. By asset type it is 98% stocks, 2% preferred stock, 0% bonds.
Updated Jul 24, 2026
FHCRX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | ELI LILLY and CO | Stocks | 8.03% | $464.1M |
| 2 | Danaher Corp | Stocks | 6.89% | $398.2M |
| 3 | JOHNSON and JOHNSON | Stocks | 4.91% | $283.9M |
| 4 | Thermo Fisher Scientific Inc | Stocks | 4.33% | $250.2M |
| 5 | Unitedhealth Group Inc | Stocks | 3.49% | $201.6M |
| 6 | Alnylam Pharmaceuticals Inc | Stocks | 2.40% | $138.9M |
| 7 | Gilead Sciences Inc | Stocks | 2.21% | $127.7M |
| 8 | Boston Scientific Corp | Stocks | 2.17% | $125.6M |
| 9 | Ascendis Pharma A/s ASCENDIS PHARMA AS |
Stocks | 2.17% | $125.5M |
| 10 | Fidelity Revere Street Trust Fidelity Securities Lending Cash Central Fund |
Cash & short-term funds | 2.17% | $125.4M |
| 11 | Abbvie Inc | Stocks | 2.03% | $117.6M |
| 12 | Ucb Sa | Stocks | 2.03% | $117.4M |
| 13 | Bio Techne Corp | Stocks | 1.70% | $98.2M |
| 14 | MERCK and CO INC MERCK and CO INC NEW |
Stocks | 1.60% | $92.6M |
| 15 | Argenx Se ARGENX SE SPONSORED ADR |
Stocks | 1.56% | $90.3M |
| 16 | Cvs Health Corp | Stocks | 1.29% | $74.6M |
| 17 | Nuvalent Inc NUVALENT INC-A |
Stocks | 1.28% | $74.0M |
| 18 | Natera Inc | Stocks | 1.27% | $73.3M |
| 19 | Brightspring Health Services Inc | Stocks | 1.23% | $70.9M |
| 20 | Viatris Inc | Stocks | 1.20% | $69.6M |
| 21 | Moderna Inc | Stocks | 1.18% | $68.4M |
| 22 | Cencora Inc | Stocks | 1.14% | $66.0M |
| 23 | West Pharmaceutical Svcs Inc | Stocks | 1.12% | $64.6M |
| 24 | Agilent Technologies Inc | Stocks | 1.10% | $63.8M |
| 25 | Edwards Lifesciences Corp | Stocks | 1.09% | $63.0M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 24, 2026